Navion Capital II Inc. remains steady in the market as it navigates recent developments.
This week, Navion Capital II Inc. (NVN-P.V) has experienced no change in its stock price, closing at C$0.06. The company continues to make headlines with its proposed qualifying transaction and ongoing developments in the healthcare sector.
Advertisement
Navion Capital II Inc.
NVN-P.V
NVN-P.V
Navion Capital II Inc.
WealthAwesomeMarket cap
$253,000
P/E
5.5x
52W high
$0.06
52W low
$0.06
1W change
+0.00%
Beta
0.65
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NVN-P's historical volatility
30-Day Vol
0.0%
Annualized
90-Day Vol
0.0%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.06 – C$0.06 |
| 60 trading days | C$0.06 | C$0.06 – C$0.06 |
| 90 trading days | C$0.06 | C$0.06 – C$0.06 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should monitor the upcoming transaction with Maple Brain Healthcare Inc. while considering the company's financial position and market activity.
Market Cap: C$253,000
Despite a modest market cap, Navion Capital II's strategic moves may attract attention in the evolving healthcare landscape.
Bull case
The proposed transaction with Maple Brain Healthcare Inc. could position Navion Capital II for growth in the expanding AI healthcare market. This partnership may enhance its business prospects and open up new opportunities in a rapidly developing sector.
Bear case
Navion Capital II's lack of profitability and a high negative return on equity could raise concerns among investors, especially given the competitive market landscape. These factors may lead to skepticism regarding the company's long-term viability.
Recent Price Action
Navion Capital II Inc. closed at C$0.06 this week, maintaining a steady position with no changes in its stock price over the past week. The performance remains consistent with a year-to-date change of 0.00%, indicating a stable trading environment.
Company News and Developments
Advertisement
Navion Capital II recently made headlines with its proposed qualifying transaction with Maple Brain Healthcare Inc., an AI software and medical device company. This non-binding letter of intent was announced on October 27, 2025, and may offer the company new growth opportunities in the healthcare sector. Additionally, there was a trading halt by the Canadian Investment Regulatory Organization on the same date due to pending news, highlighting the significance of this potential transaction.
Technical Picture
From a technical standpoint, Navion Capital II is currently trading at its 50-day and 200-day moving averages, both at C$0.06, indicating a lack of volatility and a stable price level. The stock has a beta of 0.65, suggesting lower volatility compared to the broader market. Its trading volume is consistent with the average, reflecting steady investor interest.
Financial Overview
Navion Capital II's financial metrics reveal a P/E ratio of 5.5, which may indicate undervaluation relative to its earnings potential. However, the company has a profit margin of 0.0% and a negative return on equity of -63.8%, raising concerns about its profitability and operational efficiency. As of now, the company's market cap stands at C$253,000.
Price Action Summary
As of the latest close, Navion Capital II Inc. remains at C$0.06, with no percentage change over the last day. Investors are encouraged to keep an eye on future developments, particularly regarding the proposed transaction with Maple Brain Healthcare Inc.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
